Xiaozhen Zhang

机构：Zhejiang International Studies University, Kunming Medical University, Zhejiang Cancer Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University, Nanjing Medical University · ORCID：0000-0003-3567-8789

发表论文 146 篇 · 总被引 3739 次 · h-index 34

代表论文

• Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma (2025 · Science Advances · 被引 30)
• One-step synthesis of oxygen vacancy-rich BiOBr/TiO2 composite: Ultrafast adsorption-photocatalytic performance and mechanism (2024 · Chemical Engineering Journal · 被引 29)
• Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy (2025 · 癌症：英文版 · 被引 22)
• Lactate metabolism reprogramming in PDAC: Potential for tumor therapy (2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 16)
• Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer (2025 · Nature Communications · 被引 13)
• Harnessing amino acid pathways to influence myeloid cell function in tumor immunity (2025 · Molecular Medicine · 被引 13)